Hell Hath No Fury Like a Vytorin Investigator Scorned

Sen. Chuck Grassley lobbed another round of letters at Merck and Schering-Plough today, asking the companies to explain their handling of the results of a disappointing clinical test of cholesterol drug Vytorin. The latest missives to the companies from Grassley (R-Iowa) came just a day after Vytorin took a beating at the annual scientific meeting [...]